SCHIMMEL PAUL

Average Profitability
27.77%
Insider Buys Quantity
3
Insider Buys Sum
$3.5M
Insider Sells Quantity
15
Insider Sells Sum
$25.32M

Insider Activity of SCHIMMEL PAUL

The largest purchase of all time was on 2012-02-21 and amounted to 186046 shares of Alnylam Pharmaceuticals, Inc. for $2M.

The largest sale of all time was on 2018-03-13 and amounted to 55646 shares of Alnylam Pharmaceuticals, Inc. for $8.35M.

Biography of SCHIMMEL PAUL

No biography is available at this moment.

2018-03-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
55,646
0.0579%
$150.00$8.35M-35.36%
2017-04-19PurchaseForte Biosciences, Inc.
FBRX
director
20,000
0.0979%
$10.00$200,000-14.41%
2015-04-21SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
20,000
0.0255%
$130.02$2.6M-18.97%
2015-03-19SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
18,106
0.0221%
$120.00$2.17M-13.41%
2015-03-17SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
947
0.0003%
$27.28$25,834-10.71%
2014-12-08SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0241%
$63.55$1.91M-1.11%
2014-10-28SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0238%
$55.45$1.66M+10.79%
2014-01-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.024%
$50.59$1.52M-22.12%
2013-12-20SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.028%
$38.16$1.14M+4.61%
2013-10-22SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0284%
$34.65$1.04M+9.32%
2012-02-21PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
director
186,046
0.3613%
$10.75$2M+41.4%
2009-09-10SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
31,200
0.0744%
$22.26$694,578-24.04%
2009-09-09SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
60,000
0.1444%
$22.10$1.33M-22.77%
2009-09-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
58,800
0.1408%
$22.02$1.29M-22.86%
2007-12-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
7,192
0.018%
$31.89$229,364-9.95%
2007-12-03SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
11,586
0.0288%
$32.60$377,669-12.29%
2007-11-30SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
37,222
0.0735%
$26.24$976,695-13.34%
2006-01-31PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
director
100,000
0.3221%
$13.00$1.3M+14.14%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.